In this experimental condition, 2-ME treatment (10 ng: same amount to cure preeclampsia phenotype in COMT deficient mice3) ameliorated such glucose tolerance defects, hyperinsulinemia, and insulin resistance (Fig. 3c–e). The gene discussed is COMT; the disease is hyperinsulinism.